pLVX-Puro8055 bp400800120016002000240028003200360040004400480052005600600064006800720076008000RREgp41 peptideProtein TatcPPT/CTSCMV enhancerCMV promoterMCSPGK promoterPuroRWPRE5' LTRM13 revlac operatorlac promoterCAP binding siteoriAmpRAmpR promoterSV40 poly(A) signal3' LTRHIV-1 Psi

基本信息

备注:The pLVX-Puro is a lentiviral expression vector with the constitutive CMV promoter and a puromycin resistance marker.
载体名称
pLVX-Puro
载体抗性
Ampicillin
载体长度
8055 bp
载体类型
Viral Expression & Packaging Vectors
复制子
ori
载体来源
Clontech
拷贝数
High copy number
启动子
mPGK
感受态
Stbl3

质粒操作方法

质粒复溶方法

  1. 发货形式:质粒干粉,常温运输,收到后请于 -20 ℃ 保存,先转化提质粒再使用。
  2. 收到干粉后先 5000 rpm 离心 1 min,加入 20 μl ddH₂O 溶解。质粒复测浓度与标称值可能有差距,这通常来自干粉在管中的位置、复溶效率、测量偏差与管壁吸附,建议先转化提质粒后再使用。
  3. 取 1 支 100 μl 感受态细胞冰上解冻 10 min,加入 2 μl 质粒,冰浴 30 min,42 ℃ 热激 60 s(不要摇动),再冰浴 2 min。
  4. 加入 900 μl 无抗生素 LB 液体培养基,180 rpm、37 ℃ 振荡培养 45 min(30 ℃ 培养 1–1.5 h)。
  5. 6000 rpm 离心 5 min,保留约 100 μl 上清重悬菌体,涂布到对应抗性的 LB 平板。
  6. 平板倒置 37 ℃ 培养 14 h(30 ℃ 则 20 h)。菌落过多可稀释质粒后再转化;无菌落可增加至 10 μl 质粒。建议先转克隆感受态、重提质粒后再导入表达感受态。
  7. 挑取单菌落接种 LB 液体培养基,加入对应抗生素,220 rpm 振荡培养 14 h,按试剂盒说明提取质粒。

通用质粒转化方法

  1. 取100 μL感受态细胞置于冰上解冻10 min,加入2 μL质粒,冰浴30 min;随后42 ℃热激60 s,期间不要晃动,再冰浴2 min。
  2. 加入900 μL无抗LB液体培养基,37 ℃、180 rpm振荡培养45 min(30 ℃条件下则培养1–1.5 h)。
  3. 6000 rpm离心5 min,弃上清,仅保留100 μL上清重悬菌体沉淀,涂布于对应质粒抗性的LB平板上。
  4. 平板倒置培养,37 ℃培养14 h,或30 ℃培养20 h。
  5. 挑取单菌落至LB液体培养基中,加入对应抗生素,220 rpm振荡培养14 h;根据实验需求及质粒提取试剂盒说明书提取质粒。

参考文献

  • Li X, Chen Z, Li X, Wang H. In vitro analysis of the role of tumor necrosis factor‑stimulated gene‑6 in keloid. Mol Med Rep. 2019 Feb;19(2):919-926. doi: 10.3892/mmr.2018.9767. Epub 2018 Dec 14. PMID: 30569148; PMCID: PMC6323212.
  • Abbasi Pashaki P, Rahim F, Habibi Roudkenar M, Razavi-Toosi S, Ebrahimi A. MicroRNA Tough Decoy Knockdowns miR-195 and Represses Hypertrophy in Chondrocytes. Appl Biochem Biotechnol. 2020 Jul;191(3):1056-1071. doi: 10.1007/s12010-020-03229-6. Epub 2020 Jan 20. PMID: 31956957.
  • Han X, Shi F, Guo S, Li Y, Wang H, Song C, Wu S. LINC02086 promotes cell viability and inhibits cell apoptosis in breast cancer by sponging miR-6757-5p and up-regulating EPHA2. World J Surg Oncol. 2023 Nov 27;21(1):371. doi: 10.1186/s12957-023-03245-w. PMID: 38008720; PMCID: PMC10680215.

pLVX-Puro 质粒 (编号: V010426) 注释

LOCUS       Exported                8055 bp DNA     circular SYN 10-SEP-2025
DEFINITION  Exported.
ACCESSION   V010426
VERSION     .
KEYWORDS    pLVX-Puro
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 8055)
  AUTHORS   Clontech
  TITLE     Direct Submission
REFERENCE   2  (bases 1 to 8055)
  TITLE     Direct Submission
REFERENCE   3  (bases 1 to 8055)
  TITLE     Direct Submission
REFERENCE   4  (bases 1 to 8055)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"
COMMENT     SGRef: number: 2; type: "Journal Article"
COMMENT     SGRef: number: 3; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..8055
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     source          join(6799..8055,1..6798)
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     misc_feature    46..279
                     /label=RRE
                     /note="The Rev response element (RRE) of HIV-1 allows for 
                     Rev-dependent mRNA export from the nucleus to the 
                     cytoplasm."
     CDS             464..508
                     /label=gp41 peptide
                     /note="antigenic peptide corresponding to amino acids 655
                     to 669 of the HIV envelope protein gp41 (Lutje Hulsik et 
                     al., 2013)"
     CDS             657..698
                     /label=Protein Tat
                     /note="Protein Tat from Human immunodeficiency virus type 1
                     group M subtype B (isolate WMJ22). Accession#: P12509"
     misc_feature    770..887
                     /label=cPPT/CTS
                     /note="central polypurine tract and central termination
                     sequence of HIV-1"
     enhancer        944..1247
                     /label=CMV enhancer
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        1248..1451
                     /label=CMV promoter
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     misc_feature    1545..1610
                     /label=MCS
                     /note="multiple cloning site"
     promoter        1633..2132
                     /label=PGK promoter
                     /note="mouse phosphoglycerate kinase 1 promoter"
     CDS             2153..2749
                     /label=PuroR
                     /note="puromycin N-acetyltransferase"
     misc_feature    2766..3354
                     /label=WPRE
                     /note="woodchuck hepatitis virus posttranscriptional
                     regulatory element"
     LTR             3561..4194
                     /label=5' LTR
                     /note="5' long terminal repeat (LTR) from HIV-1"
     primer_bind     complement(4323..4339)
                     /label=M13 rev
                     /note="common sequencing primer, one of multiple similar 
                     variants"
     protein_bind    complement(4347..4363)
                     /label=lac operator
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be 
                     relieved by adding lactose or 
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     promoter        complement(4371..4401)
                     /label=lac promoter
                     /note="promoter for the E. coli lac operon"
     protein_bind    complement(4416..4437)
                     /label=CAP binding site
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     rep_origin      complement(4725..5313)
                     /direction=LEFT
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"
     CDS             complement(5487..6344)
                     /label=AmpR
                     /note="beta-lactamase"
     promoter        complement(6345..6449)
                     /label=AmpR promoter
     polyA_signal    6497..6631
                     /label=SV40 poly(A) signal
                     /note="SV40 polyadenylation signal"
     LTR             6799..7432
                     /label=3' LTR
                     /note="3' long terminal repeat (LTR) from HIV-1"
     misc_feature    7479..7604
                     /label=HIV-1 Psi
                     /note="packaging signal of human immunodeficiency virus
                     type 1"